SnapSlide™ Wins Prestigious IoPP AmeriStar Award for Child-Resistant Closure Providing Single-Handed Medicine Access

Patented solution lauded for potential to help consumers with physical limitations, while reducing plastic usage compared to conventional caps.

SnapSlide, LLC, a packaging innovations company dedicated to making it easier for consumers to access, use, and store pharmaceutical products, was the only product honored in the “Drug & Pharmaceutical” category of the 2024 AmeriStar Awards presented by the Institute of Packaging Professionals (IoPP). The winning product was the company’s no-torque closure allowing single-handed opening and closing while maintaining child resistance criteria – the market’s first such adaptive packaging solution.

Applicable to numerous categories, including prescription vials and over-the-counter medicines, SnapSlide’s patented mechanism is designed to empower individuals with physical limitations. This inclusive advancement replaces conventional push-and-turn mechanics, making medication more accessible, safer, and easier to use independently for millions worldwide.

Key SnapSlide Highlights:

• No-Torque, Two-Step Opening Mechanism: Ensures easy, single-handed operation.
• Inclusive and User-Friendly: Enhances convenience and independence for consumers, especially those with arthritis or limb differences.
• Sustainability: Uses over 25% less plastic than conventional Rx packages, with 30% greater efficiency in shipping & distribution.
• Practical Integration: Designed to provide the scale and price points that the industry is accustomed to.

Significantly Improved Drug Accessibility for over 70 Million Americans

Developed as an access-centric alternative to conventional push-and-turn mechanics, SnapSlide’s technology represents a potentially life-changing innovation for the over 60 million Americans with some form of dexterity issue, including arthritis, fibromyalgia, multiple sclerosis and Parkinson’s disease. Of these, an estimated 12 million are temporarily or permanently unable to use one of their arms or hands. These include amputees, stroke/paralysis patients, and many faced with congenital birth defects, for whom conventional pharmaceutical closures are virtually impossible to open, dose, and close with one arm.

In fact, the SnapSlide closure has proven to be substantially more popular regardless of dexterity issues. In focus groups, nearly 90% of consumers preferred SnapSlide to conventional amber vial closures. Two-thirds reported they would be more loyal to brands adopting SnapSlide – and likely to switch to a competing brand if theirs did not incorporate the solution.

“Our commitment to inclusive design not only enhances user experience but also promotes medication adherence, benefiting everyone,” said Rocky Batzel, Inventor and CEO of SnapSlide, LLC. “We’re proud to be at the forefront of innovation in adaptive, access-driven pharmaceutical packaging, and are grateful to be recognized by an organization as prestigious as the IOPP.”